Cargando…
Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs
INTRODUCTION: Hereditary transthyretin amyloidosis (ATTR) is a genetic disease caused by a point mutation in the TTR gene that causes the liver to produce an unstable TTR protein. The most effective treatment has been liver transplantation in order to replace the variant TTR producing liver with one...
Autores principales: | Norgren, Nina, Olsson, Malin, Nyström, Hanna, Ericzon, Bo Göran, de Tayrac, Marie, Genin, Emmanuelle, Planté-Bordeneuve, Violaine, Suhr, Ole B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Informa UK Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4046871/ https://www.ncbi.nlm.nih.gov/pubmed/24601850 http://dx.doi.org/10.3109/13506129.2014.894908 |
Ejemplares similares
-
Allele Specific Expression of the Transthyretin Gene in Swedish Patients with Hereditary Transthyretin Amyloidosis (ATTR V30M) Is Similar between the Two Alleles
por: Norgren, Nina, et al.
Publicado: (2012) -
Non-parametric estimation of survival in age-dependent genetic disease and application to the transthyretin-related hereditary amyloidosis
por: Alarcon, Flora, et al.
Publicado: (2018) -
Guideline of transthyretin-related hereditary amyloidosis for clinicians
por: Ando, Yukio, et al.
Publicado: (2013) -
A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers
por: Olsson, Malin, et al.
Publicado: (2010) -
Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy
por: Gendre, Thierry, et al.
Publicado: (2019)